Category

Our lead therapeutic candidate, CARSKNKDC (CAR) peptide, represents a new paradigm in targeted therapy. CAR preferentially homes to, and penetrates, diseased tissue while selectively augmenting the efficacy of therapies and accelerating wound healing. CAR can selectively enhance gene